Peptide Library / Detail
Livagen
Half-life
Estimated 30-60 minutes (typical for short peptides)
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Livagen is a synthetic tripeptide with the amino acid sequence Lys-Glu-Asp (KED). It is classified as a peptide bioregulator developed as part of research into short peptides that may influence gene expression and cellular function. Livagen has been primarily investigated for its potential effects on neuroendocrine and immune system regulation.
Usage
Research protocols typically involve subcutaneous or intramuscular administration at doses ranging from 10-20 mcg per day for cycles of 10-20 days. Some protocols suggest administration once daily, often in the evening. Cycles may be repeated with rest periods between courses.
Mechanism of Action
Livagen is believed to act as a peptide bioregulator that may interact with chromatin in cell nuclei to influence gene expression. It has been studied for potential effects on neuroimmune regulation, possibly modulating cytokine production and influencing the hypothalamic-pituitary axis. The exact molecular mechanisms remain under investigation.
Benefits(6)
- May support cognitive function and mental clarity
- Potential neuroendocrine system regulation
- May influence immune system modulation
- Possible support for stress response regulation
- May contribute to overall homeostatic balance
- Potential neuroprotective properties under investigation
Side Effects(5)
- Limited safety data available from controlled studies
- Potential injection site reactions (redness, swelling)
- Unknown long-term effects
- Possible allergic reactions in sensitive individuals
- Interactions with other medications not well characterized